Financials
Financial year 2025
FIFRIMOL from Ingelmunster, company number BE0833468936, closed financial year 2025 with a result of € 159,741 after tax. For that financial year FIFRIMOL recorded a gross margin of € 206,183 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 156,885 to € 159,741. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 1.1 million
▲ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 159,741
▲ 2% vs 2024
Profit after tax over the fiscal year.
€ 167,897
▲ 72% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 935,906.
People and assets in 2025
€ 34,369
▼ 26% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 30,792
▼ 23% vs 2024
€ 9,345 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 12,472
▼ 33% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 30,590
▲ 284% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 211,480 | € 225,011 | € 201,084 | € 206,183 | ▲ 3% |
| Profit after taxes | € 174,751 | € 188,319 | € 156,885 | € 159,741 | ▲ 2% |
| Equity | € 633,712 | € 822,031 | € 921,165 | € 1,080,906 | ▲ 17% |
| Total debts | € 230,172 | € 185,208 | € 246,004 | € 229,611 | ▼ 7% |
| Cash | € 75,768 | € 69,661 | € 97,828 | € 167,897 | ▲ 72% |
| Retained profit | € 488,712 | € 677,031 | € 776,165 | € 935,906 | ▲ 21% |
| Dividend | € 59,501 | € 0 | € 57,751 | € 0 | ▼ 100% |
| Bank debt | € 0 | € 0 | € 39,805 | € 30,792 | ▼ 23% |
| Balance sheet total | € 863,884 | € 1,007,239 | € 1,167,169 | € 1,310,517 | ▲ 12% |
Key figures of FIFRIMOL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to FIFRIMOL?
What happened at FIFRIMOL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 159,741 (▲ 2% vs 2024). Source: NBB ↗
- New establishment in Ingelmunster. KBO
- Start of the company according to the CBE. KBO
In short
From € 174,751 profit in 2022 to € 159,741 profit in 2025.
Paid € 280,240 in corporate taxes since 2022.
Best year ever: 2023, with € 188,319 profit.
Paid out € 117,252 in dividends to the owners in total.
Management
Behind FIFRIMOL are Friedel Vantomme and Filip Blanckaert. It owns 100% of APOTHEEK FRIEDEL VANTOMME itself.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Stationsstraat 6
8770 Ingelmunster
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0833.468.936
- VAT number
- BE 0833.468.936
- Registered office
- Stationsstraat 6, 8770 Ingelmunster
- Names & denominations
- FIFRIMOL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 January 2011
- Peppol
- Active · Active since 5 Jan 2026
- Activities · NACE
Activiteiten van hoofdkantoren